Table 3.
Characteristics | Control* | COPD | CPFE | IPF | P value |
---|---|---|---|---|---|
All patients (N=234) | 64 | 132 | 16 | 22 | |
≥ Grade 3 RP | 1 (1.6%) | 3 (2.3%) | 1 (6.3%) | 7 (31.8%) | <0.001 |
Subgroup analysis with stage I NSCLC (N=170) | 48 | 96 | 11 | 15 | |
≥ Grade 3 RP | 0 (0.0%) | 2 (2.1%) | 1 (9.1%) | 4 (26.7%) | <0.001 |
Subgroup analysis with stage II NSCLC (N=64) | 16 | 36 | 5 | 7 | |
≥ Grade 3 RP | 1 (6.3%) | 1 (2.8%) | 0 (0.0%) | 3 (42.9%) | 0.003 |
Notes: Data are presented as n or number (%). *Non-COPD, non-CPFE, and non-IPF.
Abbreviations: COPD, chronic obstructive pulmonary disease; CPFE, combined pulmonary fibrosis and emphysema; IPF, idiopathic pulmonary fibrosis; RP, radiation pneumonitis.